BioLogic Pharma Solutions
Biologic Pharma Solutions is a biotech and pharmaceutical consulting firm that provides fractional, project-based medical affairs expertise to support product development and launch readiness. Services emphasize strategic medical affairs planning, KOL engagement, patient identification (including genetic diagnostics), congress and publication support, and regulatory alignment. The firm positions fractional staffing and rapid-deployment teams as a lower-overhead alternative to permanent hires.
Industries
Nr. of Employees
small (1-50)
BioLogic Pharma Solutions
Grand Rapids, Michigan, United States, North America
Products
Fractional Medical Affairs Consulting
Flexible, project-based medical affairs support designed to eliminate the need for costly full-time employees and ensure expert execution during product launches.
Trial Recruitment
Increasing overall patient volumes and speed of clinical trial findings.
KOL Engagement
Implementing strategies to change perceptions and behaviors among key opinion leaders.
Strategic Planning
Refining plans, validating insights, and identifying opportunities for pharmaceutical and biotech product commercialization.
LEAD Project
The LEAD (Leveraging Early genomics for Assessment of Developmental delay) initiative provides a five-stage, evidence-based pathway from a national white paper to a CME-accredited national implementation program to align pediatric practice with AAP genomic testing standards and improve early diagnosis of autism and related disorders.
Fractional Medical Affairs Consulting
Flexible, project-based medical affairs support designed to eliminate the need for costly full-time employees and ensure expert execution during product launches.
Trial Recruitment
Increasing overall patient volumes and speed of clinical trial findings.
KOL Engagement
Implementing strategies to change perceptions and behaviors among key opinion leaders.
Strategic Planning
Refining plans, validating insights, and identifying opportunities for pharmaceutical and biotech product commercialization.
LEAD Project
The LEAD (Leveraging Early genomics for Assessment of Developmental delay) initiative provides a five-stage, evidence-based pathway from a national white paper to a CME-accredited national implementation program to align pediatric practice with AAP genomic testing standards and improve early diagnosis of autism and related disorders.
Services
Medical affairs strategy development, gap analysis, launch readiness planning, and long-term strategic tracking.
Stakeholder identification and engagement, advisory board planning and facilitation, and KOL program execution.
Congress selection and ROI assessment, booth planning and management, poster and presentation support, lead capture, and post-event reporting.
Patient-finding strategies leveraging outreach and genetic diagnostic assessment to accelerate recruitment for clinical trials.
Development and execution of publication plans, slide decks, posters, and medical education materials.
Alignment of medical affairs activities with regulatory expectations to support submissions, audits, and compliance.
Medical affairs strategy development, gap analysis, launch readiness planning, and long-term strategic tracking.
Stakeholder identification and engagement, advisory board planning and facilitation, and KOL program execution.
Congress selection and ROI assessment, booth planning and management, poster and presentation support, lead capture, and post-event reporting.
Patient-finding strategies leveraging outreach and genetic diagnostic assessment to accelerate recruitment for clinical trials.
Development and execution of publication plans, slide decks, posters, and medical education materials.
Alignment of medical affairs activities with regulatory expectations to support submissions, audits, and compliance.
Expertise Areas
- Medical affairs strategy and fractional resourcing
- KOL engagement and advisory boards
- Clinical trial recruitment and patient identification
- Regulatory readiness and compliance support
Key Technologies
- Genetic diagnostics and variant analysis
- Clinical trial recruitment platforms and outreach workflows
- Customer relationship management (CRM) systems
- Medical information systems
News & Updates
Poster exploring the impact of fractional medical affairs support on radiopharmaceutical risk management and return on investment.
Publication highlighting limitations and false negatives in detection of mutations related to autism spectrum disorders.
Presentation/poster discussing genetic testing implications for Phelan-McDermid syndrome diagnostics.
Award recognizing client service excellence in biotechnology and pharmaceutical consulting.
Poster exploring the impact of fractional medical affairs support on radiopharmaceutical risk management and return on investment.
Publication highlighting limitations and false negatives in detection of mutations related to autism spectrum disorders.
Presentation/poster discussing genetic testing implications for Phelan-McDermid syndrome diagnostics.
Award recognizing client service excellence in biotechnology and pharmaceutical consulting.